Who founded Phase Biolabs?

Phase Biolabs was founded by David Ortega in 2020.

Who are Phase Biolabs's investors?

Phase Biolabs's investors include Collaborative Fund, Y Combinator, Zillionize, Asymmetry Ventures, Transition Global.

Where is Phase Biolabs headquartered?

Phase Biolabs is headquartered in Nottingham, GB.

Phase Biolabs

YC W22

Nottingham, GB · Founded 2020 · 10 employees · 5 known investors

Find your way into Phase Biolabs

Each arrow is one introduction. Sign up to fill in the first one.

11,396 people can intro you to David

Ask Xavier Quilliet to introduce you to David Ortega

You →Xavier · together at Eurofins Biopharma →David

Your email: who you already know at Phase Biolabs, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Phase Biolabs team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Phase Biolabs develops biotechnology to convert CO2 into ethanol and other chemicals for use in manufacturing, transportation fuels, and other industrial applications. The company uses biological processes to make carbon recycling economically viable at scale.

Advanced Manufacturing Biotech Circular Economy Climate Tech ClimateUnited KingdomEurope

Founders & leadership· Y Combinator alumni (W22)

Phase Biolabs was founded in 2020 by David Ortega.

David Ortega FounderDavid Ortega works on biocatalyst development using genetic engineering and AI for a platform that produces chemicals from CO2 through fermentation.

Investors · 5

Collaborative Fundlisted by Collaborative FundNew York · $500K – $1M

How we know: Y Combinator's founder network · collabfund.com · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

Zillionizelisted by ZillionizePalo Alto · $200K

Asymmetry VenturesreportedRichmond · $125K – $500K

How we know: Y Combinator's founder network · Not right? Tell us

Transition GlobalreportedLondon · $100K – $5M

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 5

PowerXPowerX develops AI-powered sensors that generate proprietary data to help corporations reduce energy consumption, water use, and emissions. The company serves large organizations looking to cut operational resource costs.

OkloOklo develops next-generation fast fission reactors for producing clean electricity at scale, with a focus on safety features and the ability to use recycled nuclear waste as fuel. The company's Aurora reactor is designed to generate up to 75 megawatts of electrical power.

HedgehogHedgehog uses AI and proprietary bioreactors to optimize fungal cultivation for producing food, biochemicals, animal feed, enzymes, and other products from fungi that can recycle waste. The company serves food and agriculture industries by unlocking new fungal-based product possibilities.

AtmoAtmo develops AI-powered weather forecasting models that process real-time satellite, ground station, radar, and ocean buoy data to deliver forecasts at high resolution and speed. The company serves governments, militaries, and industries with improved weather prediction accuracy and detail for operational decision-making.

Current FoodsCurrent Foods produces plant-based and biotech-derived seafood products, including raw tuna and smoked salmon alternatives, designed to compete on flavor, nutritional profile, cost, and supply reliability. The company targets consumers seeking sustainable seafood options without sacrificing taste or health benefits.

Companies working in the same space as Phase Biolabs.

Companies House · registry record

View on Companies House ↗

Registered name: PHASE BIOLABS LTD
Company number: 12602104
Status: Active
Company type: Private limited company
Incorporated: 14 May 2020
Registered office: Suite 2540, 37 Westminster Buildings, Theatre Square, Nottingham, NG1 6LG
Nature of business (SIC): 72110 — Research and experimental development on biotechnology
Accounts: last made up to 31 Dec 2024 · next due 30 Sept 2026
Confirmation statement: last made up to 13 May 2026 · next due 27 May 2027

Current officers · 1

David Ortega Raymundo — director, appointed 14 May 2020

Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does Phase Biolabs do?: Phase Biolabs develops biotechnology to convert CO2 into ethanol and other chemicals for use in manufacturing, transportation fuels, and other industrial applications. The company uses biological processes to make carbon recycling economically viable at scale.
Who founded Phase Biolabs?: Phase Biolabs was founded by David Ortega in 2020.
Who are Phase Biolabs's investors?: Phase Biolabs's investors include Collaborative Fund, Y Combinator, Zillionize, Asymmetry Ventures, Transition Global.
Where is Phase Biolabs headquartered?: Phase Biolabs is headquartered in Nottingham, GB.